Antibody-mediated degradation of 4R-tau restores mitochondrial membrane polarization in human induced pluripotent stem cell-derived neurons with the <i>MAPT</i> 10+16 mutation
Microtubule-associated protein tau is inextricably linked to a group of clinically diverse neurodegenerative diseases termed tauopathies. The ratio balance of the major tau splicing isoform groups (3 R- and 4 R-tau) is critical in maintaining healthy neurons. An imbalance causing excess 4 R tau is associated with diseases such as progressive supranuclear palsy and frontotemporal dementia. The mechanisms by which increased 4 R results in neuronal dysfunction and neurodegeneration are not fully understood, and progress has been limited partly by a lack of suitable tools to investigate tau isoform imbalance. This work generated novel 3 R- and 4 R-specific antibody tools and 4 R-tau degrading intracellular antibody fragment "degrabodies". These were used to probe the molecular mechanisms of excess 4 R-tau in disease-mutant induced pluripotent stem cell-derived neurons. For the first time, we demonstrate a causative link between excess 4 R-tau and mitochondrial membrane hyperpolarization with wide-ranging potential for elucidating novel therapeutic approaches to treat neurodegenerative disease.
Authors
- Terry Baker (ORCID: https://orcid.org/0000-0001-8365-084X)
- Dale Starkie (ORCID: https://orcid.org/0009-0007-0295-5758)
- Selina Wray (ORCID: https://orcid.org/0000-0003-3062-7050)
- Charles Arber (ORCID: https://orcid.org/0000-0002-9743-8134)
- Daniel Lightwood (ORCID: https://orcid.org/0000-0003-1433-7459)
Institutions
- UCB Pharma (United Kingdom) (GB)
- National Hospital for Neurology and Neurosurgery (GB)
- University College London (GB)
- UCB Pharma (Belgium) (BE)
Publication Details
- Journal
- mAbs
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1080/19420862.2024.2436102
- Primary Topic
- Neuroscience and Neuropharmacology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- UCB Pharma